These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8033539)

  • 1. A stable, multivariate extension of the log-normal survival model.
    Gamel JW; McLean IW
    Comput Biomed Res; 1994 Apr; 27(2):148-55. PubMed ID: 8033539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A stable linear algorithm for fitting the lognormal model to survival data.
    Gamel JW; Greenberg RA; McLean IW
    Comput Biomed Res; 1988 Feb; 21(1):38-47. PubMed ID: 3345651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new survival model with surviving fraction: An application to colorectal cancer data.
    Barriga GD; Cancho VG; Garibay DV; Cordeiro GM; Ortega EM
    Stat Methods Med Res; 2019 Sep; 28(9):2665-2680. PubMed ID: 29984625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proportion cured and mean log survival time as functions of tumour size.
    Gamel JW; McLean IW; Rosenberg SH
    Stat Med; 1990 Aug; 9(8):999-1006. PubMed ID: 2218200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression analysis of interval-censored survival data with covariates using log-linear models.
    Kim DK
    Biometrics; 1997 Dec; 53(4):1274-83. PubMed ID: 9423249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cure fraction estimation from the mixture cure models for grouped survival data.
    Yu B; Tiwari RC; Cronin KA; Feuer EJ
    Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint modeling of survival and longitudinal data: likelihood approach revisited.
    Hsieh F; Tseng YK; Wang JL
    Biometrics; 2006 Dec; 62(4):1037-43. PubMed ID: 17156277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parametric cure models of relative and cause-specific survival for grouped survival times.
    Gamel JW; Weller EA; Wesley MN; Feuer EJ
    Comput Methods Programs Biomed; 2000 Feb; 61(2):99-110. PubMed ID: 10661395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cure rate model with interval censored data.
    Kim YJ; Jhun M
    Stat Med; 2008 Jan; 27(1):3-14. PubMed ID: 17516589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cure fraction model with random effects for regional variation in cancer survival.
    Seppä K; Hakulinen T; Kim HJ; Läärä E
    Stat Med; 2010 Nov; 29(27):2781-93. PubMed ID: 20862662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A joint model for survival and longitudinal data measured with error.
    Wulfsohn MS; Tsiatis AA
    Biometrics; 1997 Mar; 53(1):330-9. PubMed ID: 9147598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint models for multivariate longitudinal and multivariate survival data.
    Chi YY; Ibrahim JG
    Biometrics; 2006 Jun; 62(2):432-45. PubMed ID: 16918907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REML estimation for survival models with frailty.
    McGilchrist CA
    Biometrics; 1993 Mar; 49(1):221-5. PubMed ID: 8513103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deformation of log-likelihood loss function for multiclass boosting.
    Kanamori T
    Neural Netw; 2010 Sep; 23(7):843-64. PubMed ID: 20542407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation method of the semiparametric mixture cure gamma frailty model.
    Peng Y; Zhang J
    Stat Med; 2008 Nov; 27(25):5177-94. PubMed ID: 18613271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilevel mixture cure models with random effects.
    Lai X; Yau KK
    Biom J; 2009 Jun; 51(3):456-66. PubMed ID: 19588451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies.
    Remontet L; Bossard N; Belot A; Estève J;
    Stat Med; 2007 May; 26(10):2214-28. PubMed ID: 16900570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The exponentiated exponential mixture and non-mixture cure rate model in the presence of covariates.
    Mazucheli J; Coelho-Barros EA; Achcar JA
    Comput Methods Programs Biomed; 2013 Oct; 112(1):114-24. PubMed ID: 23932336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating and modeling the cure fraction in population-based cancer survival analysis.
    Lambert PC; Thompson JR; Weston CL; Dickman PW
    Biostatistics; 2007 Jul; 8(3):576-94. PubMed ID: 17021277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous carcinoma of the head and neck: cured fraction and median survival time as functions of age, sex, histologic type, and node status.
    Gamel JW; Jones AS
    Br J Cancer; 1993 May; 67(5):1071-5. PubMed ID: 8494700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.